Filed: 8/11/2023ACC: 0000950123-23-007492
📋 What this filing means
PATIENT SQUARE CAPITAL LP filed this quarterly 13F‑HR report disclosing 2 equity positions with a total reported market value of $205.41M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
2
Positions
$205.41M
Total AUM (reported)
28.46M
Total Shares
Allocation by class
SHS$127.41M62.0%
COM$78.00M38.0%
Portfolio Concentration
Top 3$205.41M100.0%
Top 3 weight
100.0%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 28.46M
Sole
Full voting authority
28.46M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole2
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings2
Rows:
ROIVANT SCIENCES LTD
SOLEShares12.64M
TypeSH
Market value$127.41M
62.03%
Sole
12.64M
Shared
0.00
None
0.00
EARGO INC
SOLEShares15.82M
TypeSH
Market value$78.00M
37.97%
Sole
15.82M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ROIVANT SCIENCES LTDSOLE | SHS | 12.64M | SH | $127.41M 62.03% | 12.64M | 0.00 | 0.00 |
EARGO INCSOLE | COM | 15.82M | SH | $78.00M 37.97% | 15.82M | 0.00 | 0.00 |